The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.; May 3, 2017, 4:00 - 5:30 p.m.; AHCA, 2727 Mahan Dr., Bldg. 3, Conference Room D Tallahassee, FL 32308 1-888-670-3525; enter ...  

  •  

    AGENCY FOR HEALTH CARE ADMINISTRATION

    Medicaid

    The Florida Medicaid Drug Utilization Review Board announces a telephone conference call to which all persons are invited.

    DATE AND TIME: May 3, 2017, 4:00 p.m. – 5:30 p.m.

    PLACE: AHCA, 2727 Mahan Drive, Building 3, Conference Room D, Tallahassee, FL 32308, telephone conference dial: 1(888)670-3525, enter participant code: 4201652735 then #

    GENERAL SUBJECT MATTER TO BE CONSIDERED: The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.

    A copy of the agenda may be obtained by contacting: Vern.Hamilton@ahca.myflorida.com.

Document Information

Hearing Meeting:
AHCA, 2727 Mahan Dr., Bldg. 3, Conference Room D Tallahassee, FL 32308 1-888-670-3525; enter passcode 4201652735 then #
Subject:
The purpose of this interim DUR meeting is to finalize the clinical criteria for the products Exondys 51 and Spinraza.
Meeting:
telephone conference call
Contact:
Vern.Hamilton@ahca.myflorida.com